Monday, March 23, 2015
NeuroDerm Lock-Out Ending May 13, 2015
Investors (particularly shorter term traders) should be alerted to expect volatility in this stock as the clock tics down to the end of NeuroDerm's "lock out" period on May 13th. While the IPO itself represented approximately 4.5 million shares, another 12 million shares will be freed up to be traded as of that date. Close to 10 million of the 12 million are held by Capital Point Ltd. and 3 NeuroDerm directors: Shmuel Cabilly, Robert Taub and Uwe Washer. None of this information means that the shares will be made available in the market, but a potential will exist and, in any case, a perception associated with the end of the "lock-out" will likely cause a certain amount of volatility leading up to and following the May 13th date.